Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis

Researchers reported the design, synthesis, structure–activity relationship exploration and biological evaluation of a novel class of CRBN-recruiting cyclic GMP-AMP synthase (cGAS)-targeting PROTAC degraders.